Xwell (XWEL) Net Equity Issued and Repurchased (2011 - 2025)

Xwell (XWEL) posted Net Equity Issued and Repurchased of $3.7 million for Q1 2025, up 24.83% sequentially from $3.0 million in Q4 2018.

Xwell (XWEL) Net Equity Issued and Repurchased (2011 - 2025) Analysis & Trends

Xwell has reported Net Equity Issued and Repurchased for 6 years, with the latest figure at $3.7 million in Q1 2025.

Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $3.7 million in Q1 2025, while the trailing twelve-month figure through Dec 2025 was $3.7 million (up 170.42% YoY) and the FY2025 annual result came in at $3.7 million, up 176.38% from the prior year.
Net Equity Issued and Repurchased grew to $3.7 million in Q1 2025 per XWEL's latest filing, from $3.0 million in the prior quarter.
Over five years, Net Equity Issued and Repurchased peaked at $3.7 million in Q1 2025 and troughed at $3.7 million in Q1 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Net Equity Issued and Repurchased (Qtr)
1	Thermo Fisher Scientific	213.96 Bn	209.90 Bn	8.34 Bn	-
2	Danaher	140.19 Bn	135.84 Bn	3.61 Bn	-
3	Idexx Laboratories	46.17 Bn	45.97 Bn	779.09 Mn	-
4	Agilent Technologies	39.73 Bn	37.92 Bn	990.00 Mn	-
5	Iqvia Holdings	39.37 Bn	37.29 Bn	1.44 Bn	-
6	Natera	38.77 Bn	37.67 Bn	696.04 Mn	-
7	Illumina	29.91 Bn	28.75 Bn	770.00 Mn	-
8	Mettler Toledo International	28.61 Bn	28.56 Bn	650.22 Mn	-
9	Quest Diagnostics	26.20 Bn	25.57 Bn	1.03 Bn	-
10	Xwell	7.54 Mn	-9.26 Mn	2.35 Mn	-

Download Data